NOXXON announces completion of EUR 1 million capital increase
(WorldNews Germany)

NOXXON ANNOUNCES COMPLETION OF EUR1 MILLION CAPITAL INCREASE Berlin, Germany, August 15, 2019, 08.00 a.m. CEST - NOXXON Pharma N.V. (Euronext Growth Paris: ALNOX), a biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment (TME), reported today that the previously announced capital increase of EUR1 million through a private placement of shares without warrants (see press release of August 6, 2019) has been completed and that further investment is already committed for a future investment round. "We are pleased to announce the completion of the capital increase, which has placed...